Company intelligence / Profile preview

Provitro

Berlin, Berlin, Germany

Ownership: Private
Employees: ~11
Development stage: Other

Overview

Provitro AG is a German biotechnology service provider specializing in molecular-pathological services, cell culture products, and tissue microarrays for preclinical and clinical research, diagnostics, and target validation. The company is ISO 9001 and ISO 13485 certified.

Therapeutic areas: OncologyInfectious DiseasesImmunologyNeurology
Modalities: BiologicCell culture productsTissue microarrays
Industry: Molecular Diagnostics

Partnerships

Charité University Hospital BerlinBayer (via Bayer HealthCare CoLaborator incubator)

Beyond the preview

Go deeper on Provitro.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Provitro.

Explore the full profile